Currently holds positions in Genentech Inc, TerraVia Holdings Inc, Agios Pharmaceuticals Inc, Kite Pharma Inc, AVROBIO Inc and Guardant Health Inc
Position | Company | Period |
---|---|---|
Executive Vice President - Commercial Operations | Genentech Inc | Dec. 1, 2005 - |
Independent Director | TerraVia Holdings Inc | April 1, 2011 - |
Independent Director | Agios Pharmaceuticals Inc | Dec. 30, 2016 - |
Independent Director | Kite Pharma Inc | Jan. 3, 2017 - |
Independent Director | AVROBIO Inc | Jan. 1, 2018 - |
Lead Independent Director | Guardant Health Inc | Dec. 31, 2016 - |
Independent Director | Forty Seven Inc | April 1, 2018 - April 7, 2020 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2021-04-28 | 2021-04-26 |
Guardant Health Inc
(GH)
|
PS Planned sale |
538
-10.4%
159.9286,037 USD |
538 -10.4% | 159.92 | 86,037 USD | |
2021-03-29 | 2021-03-25 |
Guardant Health Inc
(GH)
|
PS Planned sale |
538
-10.4%
132.0971,064 USD |
538 -10.4% | 132.09 | 71,064 USD | |
2021-03-01 | 2021-02-25 |
Guardant Health Inc
(GH)
|
PS Planned sale |
538
-10.4%
154.0082,852 USD |
538 -10.4% | 154.00 | 82,852 USD | |
2021-01-27 | 2021-01-25 |
Guardant Health Inc
(GH)
|
PS Planned sale |
538
-10.4%
162.0087,156 USD |
538 -10.4% | 162.00 | 87,156 USD | |
2021-01-06 | 2021-01-04 |
Guardant Health Inc
(GH)
|
PS Planned sale |
2,690
-36.7%
129.23347,629 USD |
2,690 -36.7% | 129.23 | 347,629 USD | |
2020-12-30 | 2020-12-28 |
Guardant Health Inc
(GH)
|
PS Planned sale |
538
-10.4%
135.0072,630 USD |
538 -10.4% | 135.00 | 72,630 USD | |
2020-12-07 | 2020-12-03 |
Guardant Health Inc
(GH)
|
PS Planned sale |
2,690
-36.7%
120.00322,800 USD |
2,690 -36.7% | 120.00 | 322,800 USD | |
2020-11-27 | 2020-11-25 |
Guardant Health Inc
(GH)
|
PS Planned sale |
538
-10.4%
113.2860,945 USD |
538 -10.4% | 113.28 | 60,945 USD | |
2020-11-05 | 2020-11-03 |
Guardant Health Inc
(GH)
|
PS Planned sale |
2,690
-36.7%
105.28283,203 USD |
2,690 -36.7% | 105.28 | 283,203 USD | |
2020-10-28 | 2020-10-26 |
Guardant Health Inc
(GH)
|
PS Planned sale |
538
-10.4%
104.0355,968 USD |
538 -10.4% | 104.03 | 55,968 USD | |
2020-10-05 | 2020-10-05 |
Guardant Health Inc
(GH)
|
PS Planned sale |
2,690
-36.7%
108.50291,865 USD |
2,690 -36.7% | 108.50 | 291,865 USD | |
2020-10-05 | 2020-09-25 |
Guardant Health Inc
(GH)
|
PS Planned sale |
538
-10.4%
106.2457,157 USD |
538 -10.4% | 106.24 | 57,157 USD | |
2020-09-10 | 2020-09-08 |
Guardant Health Inc
(GH)
|
PS Planned sale |
1,136
-19.7%
90.54102,853 USD |
1,136 -19.7% | 90.54 | 102,853 USD | |
2020-09-10 | 2020-09-08 |
Guardant Health Inc
(GH)
|
PS Planned sale |
2,747
-32.2%
89.78246,612 USD |
2,747 -32.2% | 89.78 | 246,612 USD | |
2020-09-10 | 2020-09-08 |
Guardant Health Inc
(GH)
|
PS Planned sale |
5,263
-38.2%
88.69466,782 USD |
5,263 -38.2% | 88.69 | 466,782 USD | |
2020-06-05 | 2020-06-03 |
Guardant Health Inc
(GH)
|
PS Planned sale |
2,690
-67.4%
87.52235,429 USD |
2,690 -67.4% | 87.52 | 235,429 USD | |
2020-05-26 | 2020-05-26 |
Guardant Health Inc
(GH)
|
PS Planned sale |
538
-29.2%
98.5052,993 USD |
538 -29.2% | 98.50 | 52,993 USD | |
2020-05-06 | 2020-05-04 |
Guardant Health Inc
(GH)
|
PS Planned sale |
2,690
-67.4%
72.17194,137 USD |
2,690 -67.4% | 72.17 | 194,137 USD | |
2020-04-29 | 2020-04-27 |
Guardant Health Inc
(GH)
|
PS Planned sale |
538
-29.2%
77.5041,695 USD |
538 -29.2% | 77.50 | 41,695 USD | |
2020-04-16 | 2020-04-14 |
Guardant Health Inc
(GH)
|
PS Planned sale |
2,689
-67.4%
70.00188,230 USD |
2,689 -67.4% | 70.00 | 188,230 USD | |
2020-03-27 | 2020-03-25 |
Guardant Health Inc
(GH)
|
PS Planned sale |
538
-29.2%
70.0037,660 USD |
538 -29.2% | 70.00 | 37,660 USD | |
2020-03-04 | 2020-03-03 |
Guardant Health Inc
(GH)
|
PS Planned sale |
2,690
-67.4%
78.33210,708 USD |
2,690 -67.4% | 78.33 | 210,708 USD | |
2020-02-27 | 2020-02-25 |
Guardant Health Inc
(GH)
|
PS Planned sale |
538
-29.2%
80.0043,040 USD |
538 -29.2% | 80.00 | 43,040 USD | |
2020-02-05 | 2020-02-03 |
Guardant Health Inc
(GH)
|
PS Planned sale |
2,690
-67.4%
76.23205,059 USD |
2,690 -67.4% | 76.23 | 205,059 USD | |
2020-01-29 | 2020-01-27 |
Guardant Health Inc
(GH)
|
PS Planned sale |
538
-29.2%
77.3141,593 USD |
538 -29.2% | 77.31 | 41,593 USD | |
2020-01-07 | 2020-01-03 |
Guardant Health Inc
(GH)
|
PS Planned sale |
2,690
-67.4%
77.87209,470 USD |
2,690 -67.4% | 77.87 | 209,470 USD | |
2019-11-27 | 2019-11-25 |
Guardant Health Inc
(GH)
|
PS Planned sale |
538
-29.2%
78.1742,055 USD |
538 -29.2% | 78.17 | 42,055 USD | |
2019-10-29 | 2019-10-28 |
Guardant Health Inc
(GH)
|
PS Planned sale |
3,228
-71.3%
70.00225,960 USD |
3,228 -71.3% | 70.00 | 225,960 USD | |
2019-09-27 | 2019-09-25 |
Guardant Health Inc
(GH)
|
PS Planned sale |
538
-29.2%
72.0038,736 USD |
538 -29.2% | 72.00 | 38,736 USD | |
2019-09-05 | 2019-09-03 |
Guardant Health Inc
(GH)
|
PS Planned sale |
2,690
-67.4%
85.70230,533 USD |
2,690 -67.4% | 85.70 | 230,533 USD | |
2019-05-03 | 2019-05-03 |
Guardant Health Inc
(GH)
|
PS Planned sale |
2,690
-100.0%
65.91177,298 USD |
2,690 -100.0% | 65.91 | 177,298 USD | |
2019-04-29 | 2019-04-25 |
Guardant Health Inc
(GH)
|
PS Planned sale |
538
-100.0%
65.1135,029 USD |
538 -100.0% | 65.11 | 35,029 USD | |
2019-04-17 | 2019-04-15 |
Guardant Health Inc
(GH)
|
PS Planned sale |
81,772
-100.0%
73.906,042,951 USD |
81,772 -100.0% | 73.90 | 6,042,951 USD |